BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 25528771)

  • 21. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells.
    Oka N; Soeda A; Inagaki A; Onodera M; Maruyama H; Hara A; Kunisada T; Mori H; Iwama T
    Biochem Biophys Res Commun; 2007 Aug; 360(3):553-9. PubMed ID: 17618600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cells and their potential implications for the treatment of solid tumors.
    Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
    J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells.
    Gwak H; Haegeman G; Tsang BK; Song YS
    Mol Carcinog; 2015 Dec; 54(12):1529-40. PubMed ID: 25307508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells: the promise and the potential.
    Ajani JA; Song S; Hochster HS; Steinberg IB
    Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing the cancer stem cell hypothesis in melanoma: the clinics will tell.
    Shakhova O; Sommer L
    Cancer Lett; 2013 Sep; 338(1):74-81. PubMed ID: 23073475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.
    Okada M; Kuramoto K; Takeda H; Watarai H; Sakaki H; Seino S; Seino M; Suzuki S; Kitanaka C
    Oncotarget; 2016 May; 7(19):27021-32. PubMed ID: 27027242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells in solid tumors.
    Ailles LE; Weissman IL
    Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
    Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C
    Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.
    Sugimori M; Hayakawa Y; Boman BM; Fields JZ; Awaji M; Kozano H; Tamura R; Yamamoto S; Ogata T; Yamada M; Endo S; Kurimoto M; Kuroda S
    PLoS One; 2015; 10(8):e0135760. PubMed ID: 26284929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization and targeting of LGR5
    Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
    Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
    Liu YX; Feng JY; Sun MM; Liu BW; Yang G; Bu YN; Zhao M; Wang TJ; Zhang WY; Yuan HF; Zhang XD
    Acta Pharmacol Sin; 2019 Jan; 40(1):122-132. PubMed ID: 29925918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming 5-Fu resistance of colon cells through inhibition of Glut1 by the specific inhibitor WZB117.
    Liu W; Fang Y; Wang XT; Liu J; Dan X; Sun LL
    Asian Pac J Cancer Prev; 2014; 15(17):7037-41. PubMed ID: 25227787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
    Gao C; Shen Y; Jin F; Miao Y; Qiu X
    PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hierarchical self-recognition and response in CSC and non-CSC micro-niches for cancer therapy.
    Yang Y; Peng Y; Du Y; Lin M; Li J; Gao D; Yang Z; Wang W; Zhou Y; Li X; Yan T; Qi X
    Biomaterials; 2024 Jul; 308():122581. PubMed ID: 38640783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.